Fig. 5 Increased myometrial cell contractility in response to fetal T cells from preterm infants. Increased myometrial cell contractility in response to.

Slides:



Advertisements
Similar presentations
Identification of combination treatment–responsive dysfunctional tumor-infiltrating CD8+ T cell population. Identification of combination treatment–responsive.
Advertisements

Fibroblast activation in WT and NFATc2-deficient mice.
IFN-γ antagonizes TGF-β in vivo.
IFN-γ activates the fibrinolytic system.
VLPs activate DCs and antigen-specific CD8+ T cells via the STING and cGAS pathway. VLPs activate DCs and antigen-specific CD8+ T cells via the STING and.
TPAD training protocol.
CCR2+ monocytes are a relevant source of type I IFN in response to Af.
LV activation of DCs and subsequent CD8+ T cell priming are dependent on STING and cGAS but not on MyD88, TRIF, or MAVS. LV activation of DCs and subsequent.
Human PBMC-derived MERS-CoV–specific T cells are multifunctional.
Virus-specific T cell responses are detected in all MERS survivors.
Deficiency in myeloid-resident NRP1 affects systemic metabolism.
Power-free sterilization of culture plate.
Human cells produce type I and III IFNs upon Af stimulation.
Genetic FIP200 deletion impairs autophagy induction and causes T cell apoptosis. Genetic FIP200 deletion impairs autophagy induction and causes T cell.
Tukey boxplots overlaid on data points from objective and subjective measures, displaying results from study 1. Tukey boxplots overlaid on data points.
T-bethi MP cells produce IFN-γ in response to IL-12.
Fig. 6 In utero injection of inflammatory cytokines or adoptive transfer of activated T cells leads to pregnancy loss. In utero injection of inflammatory.
Mammary cell proliferation is inhibited when LAD1 is depleted.
IFN-γ antagonizes TGF-β in vivo.
Fig. 4. Peanut-specific TH2A cells are specifically targeted during immunotherapy. Peanut-specific TH2A cells are specifically targeted during immunotherapy.
Blood Tfr cells are indicators of ongoing humoral activity.
LIMK1 inhibition protects against Aβ-induced neuronal hyperexcitability. LIMK1 inhibition protects against Aβ-induced neuronal hyperexcitability. (A) Representative.
Fig. 4 Labeling of Msmeg with DMN-Tre is fast and specific and depends on Ag85A function. Labeling of Msmeg with DMN-Tre is fast and specific and depends.
Fig. 2 AcPGP induces IL-8 and G-CSF release from human bronchial epithelial cells. AcPGP induces IL-8 and G-CSF release from human bronchial epithelial.
Cell viability tests. Cell viability tests. SEM images of (A) MC3T3-E1 cells and (B) MSCs on days 1, 3, and 5 of culture. (C) Survival rates of MC3T3-E1.
Tumor control by necroptotic cells requires BATF3+cDC1 and CD8+leukocytes. Tumor control by necroptotic cells requires BATF3+cDC1 and CD8+leukocytes. (A)
Fig. 1. MSCs undergo in vivo apoptosis after infusion without affecting immunosuppression. MSCs undergo in vivo apoptosis after infusion without affecting.
Hypertensive mice are predisposed to autoimmune diseases.
Fig. 4. PVSRIPO infection of DCs is sublethal, is marginally productive, and induces sustained proinflammatory cytokine production. PVSRIPO infection of.
Fig. 6. Nontaxane chemotherapies induce TMEM-dependent prometastatic changes in the breast cancer microenvironment. Nontaxane chemotherapies induce TMEM-dependent.
Microrobots with different cell-carrying capacities under different grid lengths (lg) and burr lengths (lb). Microrobots with different cell-carrying capacities.
Fig. 8 Combining M7824 with radiation or chemotherapy enhances antitumor efficacy. Combining M7824 with radiation or chemotherapy enhances antitumor efficacy.
IFN-γ activates the fibrinolytic system.
T-CTLs are CD8+ TEMRA cells that can be expanded by IL-15 and IL-2 through selective proliferation and can be induced by LCs. T-CTLs are CD8+ TEMRA cells.
Shared phenotype of CD4+CLA+CD103+ T cells from human blood and skin.
Blood Tfr cells do not show specialized humoral regulatory capacity.
Fig. 3. Increased expression of exhaustion markers and apoptosis markers on CAR8 cells in the presence of TCR antigen. Increased expression of exhaustion.
Fig. 1. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy. CAR4 and CAR8 cells demonstrate in vitro and in vivo antileukemic efficacy.
Fig. 3 BMS blocks functional responses in primary immune cells driven by IL-23 and IL-12. BMS blocks functional responses in primary immune.
Fig. 7 BMS reduces the elevated expression of type I IFN–regulated genes both ex vivo in blood from patients with lupus and in a phase 1 study of.
Fig. 2 In situ vaccination of CpG in combination with anti-OX40 antibody cures established local and distant tumors. In situ vaccination of CpG in combination.
BMS blocks functional responses in primary immune cells driven by IFNα
Fig. 5 Treatment with BMS (PO BID) protects from wasting and colitis in two SCID mouse models. Treatment with BMS (PO BID) protects from.
Treating ischemia via recruitment of antigen-specific T cells
In situ concurrent removal of MRSA bacteria and MRSA-secreting PFTs by RBC-PL-robots. In situ concurrent removal of MRSA bacteria and MRSA-secreting PFTs.
Fig. 4 Cdc42 enhances the cellular uptake of EVs.
AEGIS autonomous targeting process.
Fig. 3 Local Maraba treatment of TNBC tumors provides long-term systemic protection. Local Maraba treatment of TNBC tumors provides long-term systemic.
CD25 expression predicts effector and memory differentiation.
Fig. 3 ERK5 inhibition suppresses M2 macrophage polarization, alters secreted cytokine profiles, and modifies the actin cytoskeleton. ERK5 inhibition suppresses.
Fig. 5. Vascularization of human liver seed grafts.
Fig. 3. Human liver tissue seed graft function.
Tissue architecture affects function of expanded liver seed grafts
Treg expression of Gata3 plays a major role in controlling dermal fibrosis. Treg expression of Gata3 plays a major role in controlling dermal fibrosis.
Fig. 2 In vitro and preclinical study with 18F-MPG.
Human basophils are unresponsive to contact-dependent or contact-independent inhibition by Tregs. Human basophils are unresponsive to contact-dependent.
Fig. 5. High burdens of AA signature mutations and predicted immunogenicity in Taiwan HCCs. High burdens of AA signature mutations and predicted immunogenicity.
Fig. 2 BX795 is nontoxic to HCE cells at therapeutic concentration.
Fibroblast activation in WT and NFATc2-deficient mice.
Fig. 7 BEL immune response.
IL-9–expressing TH cells are highly enriched in CCR4+/CCR8+ effector memory TH cells. IL-9–expressing THcells are highly enriched in CCR4+/CCR8+effector.
Fig. 4 Single-particle contact angle measurements.
Fig. 5 IL-5–mediated signaling is critical for the development of CD1dintCD5+ Breg precursor cells and IL-10+ Breg cells. IL-5–mediated signaling is critical.
ATP analogs have little effect on the conformation of the 2CARD domain
Fig. 6 TNF-α neutralization prevents ZIKV-induced seizures in mice.
Fig. 4 Gallium increases P. aeruginosa sensitivity to peroxides.
Fig. 6 Pharmacologic alterations of β-AR signaling regulate cardiomyocyte abscission and endowment. Pharmacologic alterations of β-AR signaling regulate.
In vivo function of MeTro sealants using rat incision model of lungs
Fig. 5. Paclitaxel promotes breast cancer cell dissemination and metastasis in a MENA-dependent manner. Paclitaxel promotes breast cancer cell dissemination.
Fig. 2. Cellular response to FolamiRs in vitro.
Presentation transcript:

Fig. 5 Increased myometrial cell contractility in response to fetal T cells from preterm infants. Increased myometrial cell contractility in response to fetal T cells from preterm infants. (A) Experimental design. Uterine myometrial cells (PHM1-41) were embedded in collagen in a 24-well plate and incubated for 2 days at 37°C. Contraction mediators/blockers or sorted fetal CD4+ and CD8+ T cells from the cord blood of healthy term controls (term) or preterm (PTL) infants were added to the cultures before releasing the stressed matrix. The gel size was measured at the indicated time points. (B) Representative graph of the percentage contraction of PHM1-41 cells embedded in collagen gel matrices treated with medium, TNF-α, or IFN-γ at 48 hours (n = 8). (C) Representative graph of the percentage contraction of PHM1-41 cells embedded in collagen gel matrices cocultured with fetal CD4+ or CD8+ T cells isolated from the cord blood of healthy term controls (term) or preterm (PTL) infants, either nontreated or treated with neutralizing antibodies for TNF-α, IFN-γ, or both, at 48 hours (n = 6). Small horizontal bars indicate the mean ± SEM. (D) Representative images of gels at 48 hours for different tested conditions. (E) IFN-γ (left) and TNF-α (right) secretion by CD4+ and CD8+ T cells from term or preterm infants either nontreated or treated with neutralizing antibodies for TNF-α or IFN-γ after 48 hours in coculture with PHM1-41 cells (n = 6). ***P < 0.001 by one-way analysis of variance (ANOVA) with Bonferroni correction. Michela Frascoli et al., Sci Transl Med 2018;10:eaan2263 Copyright © 2018 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works